Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)

2.23
Delayed Data
As of Sep 30
 -0.23 / -9.35%
Today’s Change
2.21
Today|||52-Week Range
241.26
-90.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-2.6M-4.0M-7.9M-5.6M
 
 
 
 
 
Depreciation18.3K89.1K104.2K125.7K
 
 
 
 
 
Total Other Cash Flow356.7K92.5K2.6M-1.3M
 
 
 
 
 
Funds From Operations-2.2M-3.8M-5.2M-6.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-258.6K-54.9K-245.7K-233.9K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.0M-3.8M-5.0M-6.6M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-5.1M-2.6M-6.1K
 
 
 
 
Decrease In Investments882.7K734.0K5.5M4.0M
 
 
 
 
 
Capital Expenditures-85.4K-330.6K-74.5K-182.5K
 
 
 
 
 
Fixed Asset Disposal19.8K24.8K0.000.00
 
 
 
Net Cash Flow Investing817.1K-4.7M2.8M3.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.6M9.1M4.4M3.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.6M9.1M4.4M3.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-18.0K-35.0K-190.2K345.7K
 
 
 
 
 
 
Net Change In Cash478.9K653.4K2.3M787.7K